Abstract
There has been increased interest in the last decade in the development of new vaccines, especially for pediatric use. Newer vaccines that have been licensed and recommended for widespread pediatric immunization include those for Haemophilus influenzae type b (Hib), hepatitis B (HB), and most recently in some countries varicella and Bordetella pertussis (acellular pertussis). Clinical trials are ongoing in infants for vaccines for Streptococcus pneumoniae (pneumococcal), hepatitis A (HA), and Neisseria meningitidis (meningococcal), among others. As a consequence, there is a tremendous opportunity to prevent the morbidity and mortality associated with these infectious diseases and to do so with a significantly favorable cost:benefit. However, each new vaccine would require additional injections which may become so numerous as to discourage widespread immunization. As a consequence, medical practitioners, patients, parents and others are very interested in the development of combination vaccines, whereby individual vaccines are mixed before delivery for administration in a single injection. Such mixing can take place at the point of manufacturing or filling or within a syringe or vial at the time of immunization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Allison, A.C., and Byars, N.E., 1992, Immunological adjuvants and their mode of action. In R.W. Ellis (ed.), Vaccines: New approaches to immunological problems. Stoneham, MA. Butterworth Publishers, 431–449.
Avendana, A., Ferreccia, C., Lagos, R., et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age, Pediatr Infect Dis J, 1993, 12: 638–643.
Calandra, G.B., and West, DJ. Recommendations for prevention of hepatitis B with vaccine. In R.W. Ellis (ed.), Hepatitis B vaccines in clinical practice. New York: Marcel Dekker, 1993, 1–16.
Dennehy, P.H., Saracen, C.L., and Peter, G. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection, Pediatrics, 1994, 94: 514–516.
Giebing, P.G., Hall, C.B., and Plotkin, S.A. (eds.). Reports of the Committee on Infectious Diseases, 20th ed. Elk Grove Village, IL: American Academy of Pediatrics, 1986.
Paradiso, P.R., Hogerman, D. A., Madore, D.V., et al. Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants, Pediatrics, 1993, 92: 827–832.
Sawyer, L.A., McInnis, J., Patel, A., et al. Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccine, Vaccine, 1994, 12: 851–856.
Shapiro, E.D., Berg, A.T., Austrian, R., et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine, New Eng J Med, 1991, 325, 1453–1460.
Stevens, C.E., Taylor, P.E., Tong, M.J., et al. Yeast-recombinant hepatitis B vaccine: Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission, JAMA, 1987, 257, 2612–2616.
Szmuness, W., Stevens, C.E., Zang, E.A., et al. Controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): A final report, Hepatology, 1981, 1, 377–385.
Takahashi, M., Okuno, Y, Otsuka, T., et al., Development of a live attenuated varicella vaccine. Biken, 1975, 18, 25–33.
Watemberg, N., Dagan, R., Arbelli, Y, et al. Safety and immunogenicity of Haemophilus influenzae type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants, Pediatr Infect Dis J, 1991, 10,758–763.
Weibel, R.E., Buynak, E.B., McLean, A.A., et al. Follow-up surveillance for antibody in human subjects following live attenuated measles, mumps and rubella virus vaccines. Proc Soc Exp Biol Med, 1979, 162: 328.
World Health Organization, Weekly Epidemiological Record, April 7, 1995, pp. 97-101.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ellis, R.W. (1996). Challenges in the Development of Combination Vaccines. In: Cohen, S., Shafferman, A. (eds) Novel Strategies in the Design and Production of Vaccines. Advances in Experimental Medicine and Biology, vol 397. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1382-1_17
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1382-1_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1384-5
Online ISBN: 978-1-4899-1382-1
eBook Packages: Springer Book Archive